A new drug target has been discovered to treat ALS.

An international study led by scientists at Case Western Reserve University (USA) has identified a potential therapeutic target for amyotrophic lateral sclerosis (ALS), an incurable neurodegenerative disease that affects the motor neurons responsible for voluntary movement and breathing.